Skip to content

Lorenzo Guglielmetti

  • MD, MSc
  • endTB trial, Co-PI
  • Médecins Sans Frontières; National Reference Center for Mycobacteria, Sorbonne Université
  • 8h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 200CitationsNumber of citations received by Lorenzo's publications. Updated daily.

Publications (5)

  • Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: A case-case study

    • Guglielmetti L
    • Veziris N
    • Aubry A
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Safety and efficacy of exposure to bedaquiline−delamanid in multidrug- resistant tuberculosis: a case series from France and Latvia

    N/AReaders
    N/ACitations
  • Tackling the MDR-TB epidemic in Ukraine: Every little helps ... and much more needed

    • Burman M
    • Nikolayevskyy V
    • Kontsevaya I
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement

    • van Ingen J
    • Aksamit T
    • Andrejak C
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond

    • D’Ambrosio L
    • Bothamley G
    • Caminero Luna J
    • et al.
    N/AReaders
    N/ACitations
    Get full text

Professional experience

endTB trial, Co-PI

Médecins Sans Frontières; National Reference Center for Mycobacteria, Sorbonne Université

June 2017 - Present